Search research articles
Contact Us
Filters
Showing results (61-70 of 174) with videos related to
Page
of 18
Sort By:
Cancer Chemotherapy and Pharmacology
|
May 12, 2012
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study
Alberto Zaniboni, Enrico Aitini, Sandro Barni, et al.
Journal of Translational Medicine
|
October 22, 2011
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study
Sandro Barni, Roberto Labianca, Giancarlo Agnelli, et al.
Journal of the National Cancer Institute
|
June 29, 2007
Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials
Cornelis J A Punt, Marc Buyse, Claus-Henning Köhne, et al.
Oncology
|
September 6, 2007
Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study
Marina E Cazzaniga, Luigi Dogliotti, Stefano Cascinu, et al.
Nephron. Clinical Practice
|
April 22, 2010
Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study
Flavio Gaspari, Paolo Cravedi, Mario Mandalà, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 31, 2014
Addressing the challenges of pancreatic cancer: future directions for improving outcomes
Manuel Hidalgo, Stefano Cascinu, Jörg Kleeff, et al.
Journal of Pain and Symptom Management
|
May 8, 2012
Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI--Italian questionnaire for intense episodic pain
Augusto Caraceni, Oscar Bertetto, Roberto Labianca, et al.
Journal of Translational Medicine
|
December 24, 2003
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Michele Guida, Alessandra Ravaioli, Vanna Chiarion Sileni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial
Ruggero Ridolfi, Vanna Chiarion-Sileni, Michele Guida, et al.
Critical Reviews in Oncology/Hematology
|
December 9, 2008
Rectal cancer
Maria Giulia Zampino, Roberto Labianca, Giordano D Beretta, et al.
Page
of 18
Search research articles
Search
Showing results (61-70 of 174) with videos related to
Sort By:
Page
of 18
Cancer Chemotherapy and Pharmacology
|
May 12, 2012
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study
Alberto Zaniboni, Enrico Aitini, Sandro Barni, et al.
Journal of Translational Medicine
|
October 22, 2011
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study
Sandro Barni, Roberto Labianca, Giancarlo Agnelli, et al.
Journal of the National Cancer Institute
|
June 29, 2007
Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials
Cornelis J A Punt, Marc Buyse, Claus-Henning Köhne, et al.
Oncology
|
September 6, 2007
Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study
Marina E Cazzaniga, Luigi Dogliotti, Stefano Cascinu, et al.
Nephron. Clinical Practice
|
April 22, 2010
Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study
Flavio Gaspari, Paolo Cravedi, Mario Mandalà, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
December 31, 2014
Addressing the challenges of pancreatic cancer: future directions for improving outcomes
Manuel Hidalgo, Stefano Cascinu, Jörg Kleeff, et al.
Journal of Pain and Symptom Management
|
May 8, 2012
Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI--Italian questionnaire for intense episodic pain
Augusto Caraceni, Oscar Bertetto, Roberto Labianca, et al.
Journal of Translational Medicine
|
December 24, 2003
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
Michele Guida, Alessandra Ravaioli, Vanna Chiarion Sileni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alpha-2b in advanced melanoma outpatients: results from an Italian multicenter phase III randomized clinical trial
Ruggero Ridolfi, Vanna Chiarion-Sileni, Michele Guida, et al.
Critical Reviews in Oncology/Hematology
|
December 9, 2008
Rectal cancer
Maria Giulia Zampino, Roberto Labianca, Giordano D Beretta, et al.
Page
of 18